Review



skm1 cell line  (Inserm Transfert)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Inserm Transfert skm1 cell line
    Skm1 Cell Line, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skm1+cell+line/skm1+cell+line/pm23085751-163-1-11
    Average 90 stars, based on 1 article reviews
    skm1 cell line - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia.
    Article Snippet: The SKM1 cell line was a kind gift of Patrick Auberger (INSERM U895, Nice, France), while MOLM-13, KG-1, Kasumi-1, HL-60 and MV411 cells were purchased from the DSMZ (Braunschweig, Germany).



    Similar Products

    skm1 cell line  (DSMZ)
    90
    DSMZ skm1 cell line
    Skm1 Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skm1+cell+line/skm+1/us12171744-466-64-95
    Average 90 stars, based on 1 article reviews
    skm1 cell line - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    skm1 cell line  (JCRB Cell Bank)
    90
    JCRB Cell Bank skm1 cell line
    a Immunoblots of MLL (MLL C180 ) in the indicated cell lines. b ChIP analyses at the promoter region of the MMP2 locus in the <t>SKM1</t> and THP1 cells. * P < 0.05; ** P < 0.01; the ns indicate no significant difference; two-tailed t- test. Data represent the means of triplicate reactions ± SD. c Cell viability of SKM1 was measured after 72-hour exposure to HU with co-treatment of 50 µM MM-102. d Cell viability was measured after 72-h exposure to triapine with co-treatment of 20 µM ilomastat. The IC 50 of different cells was quantified. e Cell viability of indicated cells with co-treatment of 50 µM HU and 150 nM triapine after 72 h. f immunofluorescence visualized the localization of endogenous MMP2 in SKM1 cells. Scale bar, 5 μm. g Venn diagram shows the number of candidates who interacted with MMP2 in SKM1 cells without or with the treatment of 100 μM HU after 24 h. h , i GO enrichment ( h ), and GSEA analysis ( i ) of the common 39 interaction candidates of MMP2 in SKM1 cells with or without HU treatment. j THP1 cells were transfected with full-length MMP2, with a 3× FLAG-tag. Cell fractions were prepared for the Co-IP assays using the indicated antibodies. k Relative protein synthesis of SKM1 and THP1 cells with HU treatment after the indicated hours.
    Skm1 Cell Line, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skm1+cell+line/skm+1/pmc08993889-166-0-1
    Average 90 stars, based on 1 article reviews
    skm1 cell line - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    fbs aml cell lines skm1 dsmz rpmi 1640  (DSMZ)
    95
    DSMZ fbs aml cell lines skm1 dsmz rpmi 1640
    a Immunoblots of MLL (MLL C180 ) in the indicated cell lines. b ChIP analyses at the promoter region of the MMP2 locus in the <t>SKM1</t> and THP1 cells. * P < 0.05; ** P < 0.01; the ns indicate no significant difference; two-tailed t- test. Data represent the means of triplicate reactions ± SD. c Cell viability of SKM1 was measured after 72-hour exposure to HU with co-treatment of 50 µM MM-102. d Cell viability was measured after 72-h exposure to triapine with co-treatment of 20 µM ilomastat. The IC 50 of different cells was quantified. e Cell viability of indicated cells with co-treatment of 50 µM HU and 150 nM triapine after 72 h. f immunofluorescence visualized the localization of endogenous MMP2 in SKM1 cells. Scale bar, 5 μm. g Venn diagram shows the number of candidates who interacted with MMP2 in SKM1 cells without or with the treatment of 100 μM HU after 24 h. h , i GO enrichment ( h ), and GSEA analysis ( i ) of the common 39 interaction candidates of MMP2 in SKM1 cells with or without HU treatment. j THP1 cells were transfected with full-length MMP2, with a 3× FLAG-tag. Cell fractions were prepared for the Co-IP assays using the indicated antibodies. k Relative protein synthesis of SKM1 and THP1 cells with HU treatment after the indicated hours.
    Fbs Aml Cell Lines Skm1 Dsmz Rpmi 1640, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skm1+cell+line/SKM-1/us11135198-468-90-95
    Average 95 stars, based on 1 article reviews
    fbs aml cell lines skm1 dsmz rpmi 1640 - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    skm1 cell line  (FUJIFILM)
    90
    FUJIFILM skm1 cell line
    a Immunoblots of MLL (MLL C180 ) in the indicated cell lines. b ChIP analyses at the promoter region of the MMP2 locus in the <t>SKM1</t> and THP1 cells. * P < 0.05; ** P < 0.01; the ns indicate no significant difference; two-tailed t- test. Data represent the means of triplicate reactions ± SD. c Cell viability of SKM1 was measured after 72-hour exposure to HU with co-treatment of 50 µM MM-102. d Cell viability was measured after 72-h exposure to triapine with co-treatment of 20 µM ilomastat. The IC 50 of different cells was quantified. e Cell viability of indicated cells with co-treatment of 50 µM HU and 150 nM triapine after 72 h. f immunofluorescence visualized the localization of endogenous MMP2 in SKM1 cells. Scale bar, 5 μm. g Venn diagram shows the number of candidates who interacted with MMP2 in SKM1 cells without or with the treatment of 100 μM HU after 24 h. h , i GO enrichment ( h ), and GSEA analysis ( i ) of the common 39 interaction candidates of MMP2 in SKM1 cells with or without HU treatment. j THP1 cells were transfected with full-length MMP2, with a 3× FLAG-tag. Cell fractions were prepared for the Co-IP assays using the indicated antibodies. k Relative protein synthesis of SKM1 and THP1 cells with HU treatment after the indicated hours.
    Skm1 Cell Line, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skm1+cell+line/skm1+azar++skm1+ar/pmc07836710-82-21-23
    Average 90 stars, based on 1 article reviews
    skm1 cell line - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    skm1 cell line  (Inserm Transfert)
    90
    Inserm Transfert skm1 cell line
    a Immunoblots of MLL (MLL C180 ) in the indicated cell lines. b ChIP analyses at the promoter region of the MMP2 locus in the <t>SKM1</t> and THP1 cells. * P < 0.05; ** P < 0.01; the ns indicate no significant difference; two-tailed t- test. Data represent the means of triplicate reactions ± SD. c Cell viability of SKM1 was measured after 72-hour exposure to HU with co-treatment of 50 µM MM-102. d Cell viability was measured after 72-h exposure to triapine with co-treatment of 20 µM ilomastat. The IC 50 of different cells was quantified. e Cell viability of indicated cells with co-treatment of 50 µM HU and 150 nM triapine after 72 h. f immunofluorescence visualized the localization of endogenous MMP2 in SKM1 cells. Scale bar, 5 μm. g Venn diagram shows the number of candidates who interacted with MMP2 in SKM1 cells without or with the treatment of 100 μM HU after 24 h. h , i GO enrichment ( h ), and GSEA analysis ( i ) of the common 39 interaction candidates of MMP2 in SKM1 cells with or without HU treatment. j THP1 cells were transfected with full-length MMP2, with a 3× FLAG-tag. Cell fractions were prepared for the Co-IP assays using the indicated antibodies. k Relative protein synthesis of SKM1 and THP1 cells with HU treatment after the indicated hours.
    Skm1 Cell Line, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skm1+cell+line/skm1+cell+line/pm23085751-163-1-11
    Average 90 stars, based on 1 article reviews
    skm1 cell line - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    a Immunoblots of MLL (MLL C180 ) in the indicated cell lines. b ChIP analyses at the promoter region of the MMP2 locus in the SKM1 and THP1 cells. * P < 0.05; ** P < 0.01; the ns indicate no significant difference; two-tailed t- test. Data represent the means of triplicate reactions ± SD. c Cell viability of SKM1 was measured after 72-hour exposure to HU with co-treatment of 50 µM MM-102. d Cell viability was measured after 72-h exposure to triapine with co-treatment of 20 µM ilomastat. The IC 50 of different cells was quantified. e Cell viability of indicated cells with co-treatment of 50 µM HU and 150 nM triapine after 72 h. f immunofluorescence visualized the localization of endogenous MMP2 in SKM1 cells. Scale bar, 5 μm. g Venn diagram shows the number of candidates who interacted with MMP2 in SKM1 cells without or with the treatment of 100 μM HU after 24 h. h , i GO enrichment ( h ), and GSEA analysis ( i ) of the common 39 interaction candidates of MMP2 in SKM1 cells with or without HU treatment. j THP1 cells were transfected with full-length MMP2, with a 3× FLAG-tag. Cell fractions were prepared for the Co-IP assays using the indicated antibodies. k Relative protein synthesis of SKM1 and THP1 cells with HU treatment after the indicated hours.

    Journal: Cell Death Discovery

    Article Title: Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia

    doi: 10.1038/s41420-022-00989-4

    Figure Lengend Snippet: a Immunoblots of MLL (MLL C180 ) in the indicated cell lines. b ChIP analyses at the promoter region of the MMP2 locus in the SKM1 and THP1 cells. * P < 0.05; ** P < 0.01; the ns indicate no significant difference; two-tailed t- test. Data represent the means of triplicate reactions ± SD. c Cell viability of SKM1 was measured after 72-hour exposure to HU with co-treatment of 50 µM MM-102. d Cell viability was measured after 72-h exposure to triapine with co-treatment of 20 µM ilomastat. The IC 50 of different cells was quantified. e Cell viability of indicated cells with co-treatment of 50 µM HU and 150 nM triapine after 72 h. f immunofluorescence visualized the localization of endogenous MMP2 in SKM1 cells. Scale bar, 5 μm. g Venn diagram shows the number of candidates who interacted with MMP2 in SKM1 cells without or with the treatment of 100 μM HU after 24 h. h , i GO enrichment ( h ), and GSEA analysis ( i ) of the common 39 interaction candidates of MMP2 in SKM1 cells with or without HU treatment. j THP1 cells were transfected with full-length MMP2, with a 3× FLAG-tag. Cell fractions were prepared for the Co-IP assays using the indicated antibodies. k Relative protein synthesis of SKM1 and THP1 cells with HU treatment after the indicated hours.

    Article Snippet: SKM1 (JCRB cell bank, Osaka, Japan).

    Techniques: Western Blot, Two Tailed Test, Immunofluorescence, Transfection, FLAG-tag, Co-Immunoprecipitation Assay